Pediatric Bronchiolitis Obliterans

1

Review clinical trials related to Pediatric Bronchiolitis Obliterans. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells

Bronchiolitis obliterans (BO) is a chronic lung disease which was initiated with injury of the bronchiolar epithelium and resulted in nonuniform luminal obliteration or narrowing. Among children, the most common form of BO is post-infectious BO with a lack of treatment guidelines or standard therapy. In this study, an open, single-armed study is performed to preliminarily evaluate the safety and efficacy of airway basal stem cells on treatment of pediatric BO.

Participants needed: 12
Trial details
Phase: Early Phase 1Age: 28-18Biological sex: AllType: InterventionalSponsor: Regend TherapeuticsUpdated: Jan 14, 2026Locations: 1
Eligibility criteria

Males and females, aged between 28 days and 18 years; [+5]

Subjects with bronchiolitis obliterans syndrome (BOS) who are on a current cGVHD... [+8]